S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Proteon TherapeuticsVitro DiagnosticsTitan PharmaceuticalsGenetic TechnologiesVaxart
SymbolNASDAQ:PRTOOTCMKTS:VODGNASDAQ:TTNPNASDAQ:GENENASDAQ:VXRT
Price Information
Current Price$0.26$0.20$0.37$1.85$0.38
52 Week RangeHoldN/AHoldN/ABuy
Analyst Ratings
Consensus RecommendationHoldN/AHoldN/ABuy
Consensus Price Target$3.33N/A$4.00N/A$4.00
% Upside from Price Target1,182.05% upsideN/A988.44% upsideN/A961.01% upside
Trade Information
Market Cap$5.05 million$4.82 million$7.36 million$7.63 million$5.95 million
Beta0.442.191.183.660.57
Average Volume825,43416,149754,355111,551587,385
Sales & Book Value
Annual RevenueN/AN/A$6.62 million$20,000.00$4.16 million
Price / SalesN/AN/A0.95407.651.43
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.06) per shareN/A$0.53 per share$0.29 per share$1.57 per share
Price / BookN/AN/A0.696.380.24
Profitability
Net Income$-20,730,000.00N/A$-9,020,000.00$-4,600,000.00$-18,000,000.00
EPS($1.15)N/A($0.79)N/A($2.65)
Trailing P/E RatioN/A0.00N/A0.00N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-352.17%N/A-244.38%
Return on Equity (ROE)N/AN/A-412.65%N/A-131.05%
Return on Assets (ROA)-107.30%N/A-138.30%N/A-48.79%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A1.18%N/A0.09%
Current Ratio5.41%3.50%1.27%2.14%2.29%
Quick Ratio5.41%3.21%0.96%2.14%2.29%
Ownership Information
Institutional Ownership Percentage24.00%N/A4.97%13.51%12.51%
Insider Ownership Percentage45.70%27.74%6.50%N/A7.30%
Miscellaneous
Employees17N/A23N/A34
Shares Outstanding19.59 million24.12 million17.11 million4.41 million15.79 million
Next Earnings Date11/6/2019 (Estimated)N/A11/13/2019 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable
 Proteon TherapeuticsVitro DiagnosticsTitan PharmaceuticalsGenetic TechnologiesVaxart

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel